Abra RM - Search Results

1

Liposome disposition in vivo: effects of pre-dosing with lipsomes.

Abra RM, Bosworth ME, Hunt CA. Abra RM, et al. Res Commun Chem Pathol Pharmacol. 1980 Aug;29(2):349-60. Res Commun Chem Pathol Pharmacol. 1980. PMID: 7414053

2

Liposome disposition in vivo. III. Dose and vesicle-size effects.

Abra RM, Hunt CA. Abra RM, et al. Biochim Biophys Acta. 1981 Dec 23;666(3):493-503. doi: 10.1016/0005-2760(81)90311-8. Biochim Biophys Acta. 1981. PMID: 7034780

3

Liposome disposition in vivo IV: the interaction of sequential doses of liposomes having different diameters.

Abra RM, Hunt CA. Abra RM, et al. Res Commun Chem Pathol Pharmacol. 1982 Apr;36(1):17-31. Res Commun Chem Pathol Pharmacol. 1982. PMID: 7079585

4

Delivery of therapeutic doses of doxorubicin to the mouse lung using lung-accumulating liposomes proves unsuccessful.

Abra RM, Hunt CA, Fu KK, Peters JH. Abra RM, et al. Cancer Chemother Pharmacol. 1983;11(2):98-101. doi: 10.1007/BF00254254. Cancer Chemother Pharmacol. 1983. PMID: 6627602

5

Liposome disposition in vivo. VI: Delivery to the lung.

Abra RM, Hunt CA, Lau DT. Abra RM, et al. J Pharm Sci. 1984 Feb;73(2):203-6. doi: 10.1002/jps.2600730214. J Pharm Sci. 1984. PMID: 6707883

6

The use of a new radioactive-iodine labeled lipid marker to follow in vivo disposition of liposomes: comparison with an encapsulated aqueous space marker.

Abra RM, Schreier H, Szoka FC. Abra RM, et al. Res Commun Chem Pathol Pharmacol. 1982 Aug;37(2):199-213. Res Commun Chem Pathol Pharmacol. 1982. PMID: 7134628

7

Chemoprevention and therapy of mouse mammary carcinomas with doxorubicin encapsulated in sterically stabilized liposomes.

Vaage J, Donovan D, Loftus T, Abra R, Working P, Huang A. Vaage J, et al. Cancer. 1994 May 1;73(9):2366-71. doi: 10.1002/1097-0142(19940501)73:9<2366::aid-cncr2820730920>3.0.co;2-6. Cancer. 1994. PMID: 8168041

8

Tissue distribution and therapeutic effect of intravenous free or encapsulated liposomal doxorubicin on human prostate carcinoma xenografts.

Vaage J, Barberá-Guillem E, Abra R, Huang A, Working P. Vaage J, et al. Cancer. 1994 Mar 1;73(5):1478-84. doi: 10.1002/1097-0142(19940301)73:5<1478::aid-cncr2820730526>3.0.co;2-1. Cancer. 1994. PMID: 8111716

9

Therapy of human ovarian carcinoma xenografts using doxorubicin encapsulated in sterically stabilized liposomes.

Vaage J, Donovan D, Mayhew E, Abra R, Huang A. Vaage J, et al. Cancer. 1993 Dec 15;72(12):3671-5. doi: 10.1002/1097-0142(19931215)72:12<3671::aid-cncr2820721219>3.0.co;2-u. Cancer. 1993. PMID: 8252484

10

Therapy of a xenografted human colonic carcinoma using cisplatin or doxorubicin encapsulated in long-circulating pegylated stealth liposomes.

Vaage J, Donovan D, Wipff E, Abra R, Colbern G, Uster P, Working P. Vaage J, et al. Int J Cancer. 1999 Jan 5;80(1):134-7. doi: 10.1002/(sici)1097-0215(19990105)80:1<134::aid-ijc24>3.0.co;2-q. Int J Cancer. 1999. PMID: 9935243

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters